Engineering molecular circuits using synthetic biology in mammalian cells

Annual Review of Chemical and Biomolecular Engineering

Volumn 3, Issue , 2012, Pages 209-234

  Wieland, Markus ^a   Fussenegger, Martin ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Aptamer; Artificial networks; Prosthetic networks; Transcriptional regulators

Indexed keywords

APTAMERS; ARTIFICIAL INSEMINATION; ARTIFICIAL NETWORKS; ARTIFICIAL RNA; AUTOREGULATED EXPRESSION; BOOLEAN CALCULATION; CIRCADIAN CLOCK; FUSION PROTEINS; GENETIC CONTROL; GLUCOSE HOMEOSTASIS; INNOVATIVE APPROACHES; MAMMALIAN CELLS; MOLECULAR CIRCUITS; PHYSIOLOGICAL ACTIVITY; REGULATORY ELEMENTS; SYNTHETIC BIOLOGY; SYNTHETIC GENES; TRANSCRIPTIONAL REGULATOR;

ANIMAL CELL CULTURE; ANIMALS; CELL ENGINEERING; GENES; GLUCOSE; PHYSIOLOGY; RNA; TRANSCRIPTION; UREA;

SCAFFOLDS (BIOLOGY);

HYBRID PROTEIN;

ANIMAL; CYTOLOGY; EUKARYOTIC CELL; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; MAMMAL; METABOLIC ENGINEERING; METABOLISM; METHODOLOGY; MOLECULAR COMPUTER; PROTEIN SYNTHESIS; REGULATORY SEQUENCE; REVIEW; SIGNAL TRANSDUCTION; SYNTHETIC BIOLOGY;

ANIMALS; COMPUTERS, MOLECULAR; EUKARYOTIC CELLS; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; MAMMALS; METABOLIC ENGINEERING; PROTEIN BIOSYNTHESIS; RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; SIGNAL TRANSDUCTION; SYNTHETIC BIOLOGY;

EID: 84862666539     PISSN: 19475438     EISSN: None     Source Type: Journal    
DOI: 10.1146/annurev-chembioeng-061010-114145     Document Type: Review

References (124)

1. Davidson EH. 2010. Emerging properties of animal gene regulatory networks. Nature 468:911-20
2. ErwinDH, Davidson EH. 2009. The evolution of hierarchical gene regulatory networks. Nat. Rev. Genet. 10:141-48
3. Doherty CJ, Kay SA. 2010. Circadian control of global gene expression patterns. Annu. Rev. Genet. 44:419-44
4. Michalodimitrakis K, Isalan M. 2009. Engineering prokaryotic gene circuits. FEMS Microbiol Rev. 33:27-37
5. Nevins JR. 1991. Transcriptional activation by viral regulatory proteins. Trends Biochem. Sci. 16:435-39
6. Schmitz ML, Baeuerle PA. 1991. The P65 subunit is responsible for the strong transcription activating potential of NF-kB. EMBO J. 10:3805-17
7. Ginsberg D, Vairo G, Chittenden T, Xiao ZX, Xu G, et al. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8:2665-79
8. Deuschle U, MeyerWK, Thiesen HJ. 1995. Tetracycline-reversible silencing of eukaryotic promoters. Mol. Cell. Biol. 15:1907-14
9. Boch J. 2011. TALEs of genome targeting. Nat. Biotechnol. 29:135-36
10. Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, et al. 2009. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326:1509-12
11. Moscou MJ, Bogdanove AJ. 2009. A simple cipher governs DNA recognition by TAL effectors. Science 326:1501
12. Miller JC, Tan S, Qiao G, Barlow KA,Wang J, et al. 2011. A TALE nuclease architecture for efficient genome editing. Nat. Biotechnol. 29:143-48
13. Geißler R, Scholze H, Hahn S, Streubel J, Bonas U, et al. 2011. Transcriptional activators of human genes with programmable DNA-specificity. PLoS ONE 6:e19509
14. Bae K-H, Kwon YD, Shin H-C, Hwang M-S, Ryu E-H, et al. 2003. Human zinc fingers as building blocks in the construction of artificial transcription factors. Nat. Biotechnol. 21:275-80
15. Passananti C, Corbi N, Onori A, Di Certo MG,Mattei E. 2010. Transgenic mice expressing an artificial zinc finger regulator targeting an endogenous gene. Methods Mol. Biol. 649:183-206
16. Blancafort P, Segal DJ, Barbas CF 3rd. 2004. Designing transcription factor architectures for drug discovery. Mol. Pharmacol. 66:1361-71
17. CorbiN, Libri V, Onori A, PassanantiC. 2004. Synthetic zinc finger peptides: old and novel applications. Biochem. Cell Biol. 82:428-36
18. ClarkKJ, VoytasDF, Ekker SC. 2011. A TALE of two nucleases: gene targeting for the masses? Zebrafish 8:147-49
19. Liberles SD, Diver ST, Austin DJ, Schreiber SL. 1997. Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. Proc. Natl. Acad. Sci. USA 94:7825-30
20. Pollock R, Clackson T. 2002. Dimerizer-regulated gene expression. Curr. Opin. Biotechnol. 13:459-67
21. Ho SN, Biggar SR, Spencer DM, Schreiber SL, Crabtree GR. 1996. Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature 382:822-26
22. Kay SA, Imaizumi T, Tran HG, Swartz TE, Briggs WR. 2003. FKF1 is essential for photoperiodicspecific light signalling in Arabidopsis. Nature 426:302-6
23. Huq E, Tepperman JM, Quail PH. 2000. GIGANTEA is a nuclear protein involved in phytochrome signaling in Arabidopsis. Proc. Natl. Acad. Sci. USA 97:9789-94
24. Dolmetsch RE, Yazawa M, Sadaghiani AM, Hsueh B. 2009. Induction of protein-protein interactions in live cells using light. Nat. Biotechnol. 27:941-45
25. GossenM, Bujard H. 1992. Tight control of gene expression in mammalian cells by tetracyclineresponsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-51
26. Ramos JL, Martinez-Bueno M, Molina-Henares AJ, Teran W, Watanabe K, et al. 2005. The TetR family of transcriptional repressors. Microbiol. Mol. Biol. Rev. 69:326-56
27. GossenM, Freundlieb S, Bender G,Muller G, HillenW, Bujard H. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-69
28. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W. 2000. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. USA 97:7963-68
29. 5G operator variant. Gene 404:93-100
30. Helbl V, Tiebel B,HillenW. 1998. Stepwise selection of TetR variants recognizing tet operator 6C with high affinity and specificity. J. Mol. Biol. 276:319-24
31. Scholz O, KostnerM, Reich M, Gastiger S, HillenW. 2003. Teaching TetR to recognize a new inducer. J. Mol. Biol. 329:217-27
32. Zhou X, Symons J, Hoppes R, Krueger C, Berens C, et al. 2007. Improved single-chain transactivators of the Tet-On gene expression system. BMC Biotechnol. 7:6
33. Krueger C, Berens C, Schmidt A, Schnappinger D, Hillen W. 2003. Single-chain Tet transregulators. Nucleic Acids Res. 31:3050-56
34. Hayakawa T, Yusa K, KounoM, Takeda J, Horie K. 2006. Bloom's syndrome gene-deficient phenotype in mouse primary cells induced by a modified tetracycline-controlled trans-silencer. Gene 369:80-89
35. Hartenbach S, Daoud-El Baba M, Weber W, Fussenegger M. 2007. An engineered L-arginine sensor of Chlamydia pneumoniae enables arginine-adjustable transcription control in mammalian cells and mice. Nucleic Acids Res. 35:e136
36. Weber W, Bacchus W, Gruber F, Hamberger M, Fussenegger M. 2007. A novel vector platform for vitamin H-inducible transgene expression in mammalian cells. J. Biotechnol. 131:150-58
37. Kemmer C, Gitzinger M, Daoud-El Baba M, Djonov V, Stelling J, Fussenegger M. 2010. Selfsufficient control of urate homeostasis in mice by a synthetic circuit. Nat. Biotechnol. 28:355-60
38. Weber W, Fux C, Daoud-El Baba M, Keller B, Weber CC, et al. 2002. Macrolide-based transgene control in mammalian cells and mice. Nat. Biotechnol. 20:901-7
39. Fussenegger M, Morris RP, Fux C, Rimann M, von Stockar B, et al. 2000. Streptogramin-based gene regulation systems for mammalian cells. Nat. Biotechnol. 18:1203-8
40. Gitzinger M, Kemmer C, El-Baba MD, Weber W, Fussenegger M. 2009. Controlling transgene expression in subcutaneous implants using a skin lotion containing the apple metabolite phloretin. Proc. Natl. Acad. Sci. USA 106:10638-43
41. Malphettes L, Weber CC, El-Baba MD, Schoenmakers RG, Aubel D, et al. 2005. A novel mammalian expression system derived from components coordinating nicotine degradation in Arthrobacter nicotinovorans pAO1. Nucleic Acids Res. 33:e107
42. Malphettes L, Schoenmakers RG, FusseneggerM. 2006. 6-hydroxy-nicotine- inducible multilevel transgene control in mammalian cells. Metab. Eng. 8:543-53
43. Weber W, Schoenmakers R, Keller B, Gitzinger M, Grau T, et al. 2008. A synthetic mammalian gene circuit reveals antituberculosis compounds. Proc. Natl. Acad. Sci. USA 105:9994-98
44. Weber W, Luzi S, Karlsson M, Sanchez-Bustamante CD, Frey U, et al. 2009. A synthetic mammalian electro-genetic transcription circuit. Nucleic Acids Res. 37:e33
45. Weber W, Rimann M, Spielmann M, Keller B, Daoud-El Baba M, et al. 2004. Gas-inducible transgene expression in mammalian cells and mice. Nat. Biotechnol. 22:1440-44
46. Durocher Y, Perret S, Thibaudeau E, Gaumond MH, Kamen A, et al. 2000. A reporter gene assay for high-throughput screening of G-protein-coupled receptors stably or transiently expressed in HEK293 EBNA cells grown in suspension culture. Anal. Biochem. 284:316-26
47. Ho MK, Su Y, Yeung WW, Wong YH. 2009. Regulation of transcription factors by heterotrimeric G proteins. Curr. Mol. Pharmacol. 2:19-31
48. Fire A, Xu SQ, Montgomery MK, Kostas SA, Driver SE, Mello CC. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-11
49. Couzin J. 2006. Nobel Prize in Physiology or Medicine. Method to silence genes earns loud praise. Science 314:34
50. Jaskiewicz L, Filipowicz W. 2008. Role of Dicer in posttranscriptional RNA silencing. Curr. Top. Microbiol. Immunol. 320:77-97
51. Macrae IJ, Zhou K, Li F, Repic A, Brooks AN, et al. 2006. Structural basis for double-stranded RNA processing by Dicer. Science 311:195-98
52. Matzke MA, Birchler JA. 2005. RNAi-mediated pathways in the nucleus. Nat. Rev. Genet. 6:24-35
53. Pickford AS, Cogoni C. 2003. RNA-mediated gene silencing. Cell Mol. Life Sci. 60:871-82
54. Agrawal N, Dasaradhi PV,Mohmmed A,Malhotra P, Bhatnagar RK, Mukherjee SK. 2003. RNA interference: biology, mechanism, and applications. Microbiol. Mol. Biol. Rev. 67:657-85
55. Dickins RA, Hemann MT, Zilfou JT, Simpson DR, Ibarra I, et al. 2006. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat. Genet. 37:1289-95
56. Malphettes L, Fussenegger M. 2004. Macrolide-and tetracycline-adjustable siRNA-mediated gene silencing in mammalian cells using polymerase II-dependent promoter derivatives. Biotechnol. Bioeng. 88:417-25
57. Wu RH, Cheng TL, Lo SR,Hsu HC,Hung CF, et al. 2007. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells. J. Gene Med. 9:620-34
58. Greber D, El-BabaMD, FusseneggerM. 2008. Intronically encoded siRNAs improve dynamic range of mammalian gene regulation systems and toggle switch. Nucleic Acids Res. 36:e101
59. Li X, Liu S, Wang D, Chen H, Xia H. 2011. Adenoviral delivered eGFP-intron splicing system for multiple gene RNAi. Biotechnol. Lett. 33:1723-28
60. Lin SL, Kim H, Ying SY. 2008. Intron-mediated RNA interference and microRNA (miRNA). Front. Biosci. 13:2216-30
61. Qiu L, Wang H, Xia X, Zhou H, Xu Z. 2008. A construct with fluorescent indicators for conditional expression of miRNA. BMC Biotechnol. 8:77
62. Famulok M, Mayer G. 1999. Aptamers as tools in molecular biology and immunology. Curr. Top. Microbiol. Immunol. 243:123-36
63. Beisel CL, Bayer TS, Hoff KG, Smolke CD. 2008. Model-guided design of ligand-regulated RNAi for programmable control of gene expression. Mol. Syst. Biol. 4:224
64. Ellington AD, Szostak JW. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature 346:818-22
65. Stoltenburg R, Reinemann C, Strehlitz B. 2007. SELEX-a (r)evolutionary method to generate highaffinity nucleic acid ligands. Biomol. Eng. 24:381-403
66. Patel DJ, Suri AK, Jiang F, Jiang L, Fan P, et al. 1997. Structure, recognition and adaptive binding in RNA aptamer complexes. J. Mol. Biol. 272:645-64
67. Schwalbe H, Buck J, Furtig B, Noeske J, Wohnert J. 2007. Structures of RNA switches: insight into molecular recognition and tertiary structure. Angew. Chem. Int. Ed. Engl. 46:1212-19
68. Jenison RD, Gill SC, Pardi A, Polisky B. 1994. High-resolution molecular discrimination by RNA. Science 263:1425-29
69. An CI, Trinh VB, Yokobayashi Y. 2006. Artificial control of gene expression in mammalian cells by modulating RNA interference through aptamer-small molecule interaction. RNA 12:710-16
70. SaitoH, Fujita Y, Kashida S, Hayashi K, Inoue T. 2011. Synthetic human cell fate regulation by proteindriven RNA switches. Nat. Commun. 2:160
71. Yokobayashi Y, Kumar D, An CI. 2009. Conditional RNA interference mediated by allosteric ribozyme. J. Am. Chem. Soc. 131:13906-7
72. Yen L, Magnier M, Weissleder R, Stockwell BR, Mulligan RC. 2006. Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries. RNA 12:797-806
73. Yen L, Svendsen J, Lee JS, Gray JT, Magnier M, et al. 2004. Exogenous control of mammalian gene expression through modulation of RNA self-cleavage. Nature 431:471-76
74. Auslander S, Ketzer P, Hartig JS. 2010. A ligand-dependent hammerhead ribozyme switch for controlling mammalian gene expression. Mol. Biosyst. 6:807-14
75. Culler SJ, Hoff KG, Smolke CD. 2010. Reprogramming cellular behavior with RNA controllers responsive to endogenous proteins. Science 330:1251-55
76. Harvey I, Garneau P, Pelletier J. 2002. Inhibition of translation by RNA-small molecule interactions. RNA 8:452-63
77. Green MR, Werstuck G. 1998. Controlling gene expression in living cells through small molecule-RNA interactions. Science 282:296-98
78. Saito H, Kobayashi T, Hara T, Fujita Y, Hayashi K, et al. 2010. Synthetic translational regulation by an L7Ae-kink-turn RNP switch. Nat. Chem. Biol. 6:71-78
79. Allain FHT, Auweter SD, Oberstrass FC. 2006. Sequence-specific binding of single-stranded RNA: Is there a code for recognition? Nucleic Acids Res. 34:4943-59
80. Dong S, Wang Y, Cassidy-Amstutz C, Lu G, Bigler R, et al. 2011. Specific and modular binding code for cytosine recognition in Pumilio/FBF (PUF) RNA-binding domains. J. Biol. Chem. 286:26732-42
81. Wang Y, Cheong CG,Hall TM,Wang Z. 2009. Engineering splicing factors with designed specificities. Nat. Methods 6:825-30
82. Banaszynski LA, Chen L-c, Maynard-Smith LA, Ooi AGL, Wandless TJ. 2006. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 126:995-1004
83. Ciechanover A. 1998. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J. 17:7151-60
84. Callis J, Dreher KA, Brown J, Saw RE. 2006. The Arabidopsis Aux/IAA protein family has diversified in degradation and auxin responsiveness. Plant Cell 18:699-714
85. Tan X, Calderon-Villalobos LI, Sharon M, Zheng C, Robinson CV, et al. 2007. Mechanism of auxin perception by the TIR1 ubiquitin ligase. Nature 446:640-45
86. NishimuraK, Fukagawa T, TakisawaH,Kakimoto T,KanemakiM. 2009. An auxin-based degron system for the rapid depletion of proteins in nonplant cells. Nat. Methods 6:917-22
87. Siciliano V, Menolascina F, Marucci L, Fracassi C, Garzilli I, et al. 2011. Construction and modelling of an inducible positive feedback loop stably integrated in a mammalian cell-line. PLoS Comput. Biol. 7:1002074
88. Kramer BP, Weber W, Fussenegger M. 2003. Artificial regulatory networks and cascades for discrete multilevel transgene control in mammalian cells. Biotechnol. Bioeng. 83:810-20
89. Bleris L, Xie Z, Glass D, Adadey A, Sontag E, Benenson Y. 2011. Synthetic incoherent feedforward circuits show adaptation to the amount of their genetic template. Mol. Syst. Biol. 7:519
90. Tigges M, Denervaud N, Greber D, Stelling J, Fussenegger M. 2010. A synthetic low-frequency mammalian oscillator. Nucleic Acids Res. 38:2702-11
91. WeberW, Kramer BP, FusseneggerM. 2007. A genetic time-delay circuitry in mammalian cells. Biotechnol. Bioeng. 98:894-902
92. Kramer BP, Fischer C, Fussenegger M. 2004. BioLogic gates enable logical transcription control in mammalian cells. Biotechnol. Bioeng. 87:478-84
93. Leisner M, Bleris L, Lohmueller J, Xie Z, Benenson Y. 2010. Rationally designed logic integration of regulatory signals in mammalian cells. Nat. Nanotechnol. 5:666-70
94. Greber D, Fussenegger M. 2010. An engineered mammalian band-pass network. Nucleic Acids Res. 38:e174
95. Kramer BP, Viretta AU, El Baba MD, Aubel D, Weber W, Fussenegger M. 2004. An engineered epigenetic transgene switch in mammalian cells. Nat. Biotechnol. 22:867-70
96. Ueda HR, Hayashi S, Chen W, Sano M, Machida M, et al. 2005. System-level identification of transcriptional circuits underlying mammalian circadian clocks. Nat. Genet. 37:187-92
97. Ukai-Tadenuma M, Kasukawa T, Ueda HR. 2008. Proof-by-synthesis of the transcriptional logic of mammalian circadian clocks. Nat. Cell Biol. 10:1154-63
98. Rey G, Cesbron F, Rougemont J, Reinke H, Brunner M, Naef F. 2011. Genome-wide and phasespecific DNA-binding rhythms of BMAL1 control circadian output functions in mouse liver. PLoS Biol. 9:e1000595
99. Tigges M, Marquez-Lago TT, Stelling J, Fussenegger M. 2009. A tunable synthetic mammalian oscillator. Nature 457:309-12
100. Swinburne IA, Miguez DG, Landgraf D, Silver PA. 2008. Intron length increases oscillatory periods of gene expression in animal cells. Genes Dev. 22:2342-46
101. Wurster SE, Maher LJ 3rd. 2008. Selection and characterization of anti-NF-kB p65 RNA aptamers. RNA 14:1037-47
102. Jeong S, Lee HK, Kwak HY, Hur J, Kim IA, et al. 2007. β-Catenin regulates multiple steps of RNA metabolism as revealed by the RNA aptamer in colon cancer cells. Cancer Res. 67:9315-21
103. Sayed D, Abdellatif M. 2011. MicroRNAs in development and disease. Physiol. Rev. 91:827-87
104. Brase JC, Wuttig D, Kuner R, Sultmann H. 2010. Serum microRNAs as non-invasive biomarkers for cancer. Mol. Cancer 9:306
105. Xie Z, Wroblewska L, Prochazka L, Weiss R, Benenson Y. 2011. Multi-input RNAi-based logic circuit for identification of specific cancer cells. Science 333:1307-11
106. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-33
107. Chen YY, Jensen MC, Smolke CD. 2010. Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems. Proc. Natl. Acad. Sci. USA 107:8531-36
108. Shimizu A, Kondo S, Sabe H, Ishida N, Honjo T. 1986. Structure and function of the interleukin 2 receptor: affinity conversion model. Immunol. Rev. 92:103-20
109. Auslander S, Wieland M, Fussenegger M. 2011. Smart medication through combination of synthetic biology and cell microencapsulation. Metab. Eng. In press
110. Parsons GB, Souza DW, Wu H, Yu D, Wadsworth SG, et al. 2007. Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes. Gene Ther. 14:38-48
111. Ye HF, Daoud-El Baba M, Peng RW, Fussenegger M. 2011. A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice. Science 332:1565-68
112. Walker MT, Brown RL, Cronin TW, Robinson PR. 2008. Photochemistry of retinal chromophore in mouse melanopsin. Proc. Natl. Acad. Sci. USA 105:8861-65
113. Panda S,Nayak SK, Campo B, Walker JR,Hogenesch JB, Jegla T. 2005. Illumination of the melanopsin signaling pathway. Science 307:600-4
114. Fussenegger M, Fluri DA, Kemmer C, Baba MDE. 2008. A novel system for trigger-controlled drug release from polymer capsules. J. Control. Release 131:211-19
115. Hartenbach S, BabaMDE,WeberW,FusseneggerM. 2007. An engineered L-arginine sensor of Chlamydia pneumoniae enables arginine-adjustable transcription control in mammalian cells and mice. Nucleic Acids Res. 35:e136
116. Yasuhara T, Kobayashi K, Agari T, Muraoka K, KamedaM, et al. 2006. Control of dopamine-secretion by Tet-Off system in an in vivo model of parkinsonian rat. Brain Res. 1102:1-11
117. Weber W, Lienhart C, Baba MDE, Fussenegger M. 2009. A biotin-triggered genetic switch in mammalian cells and mice. Metab. Eng. 11:117-24
118. Cameron MA, Sakhaee K. 2007. Uric acid nephrolithiasis. Urol. Clin. North Am. 34:335-46
119. Kutzing MK, Firestein BL. 2008. Altered uric acid levels and disease states. J. Pharmacol. Exp. Ther. 324:1-7
120. Wilkinson SP, Grove A. 2004. HucR, a novel uric acid-responsive member of the MarR family of transcriptional regulators from Deinococcus radiodurans. J. Biol. Chem. 279:51442-50
121. Endou H, Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, et al. 2002. Molecular identification of a renal urate-anion exchanger that regulates blood urate levels. Nature 417:447-52
122. Legoux R, Delpech B, Dumont X, Guillemot JC, Ramond P, et al. 1992. Cloning and expression in Escherichia coli of the gene encoding Aspergillus flavus urate oxidase. J. Biol. Chem. 267:8565-70
123. Ascoli M, Fanelli F, Segaloff DL. 2002. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr. Rev. 23:141-74
124. Kemmer C, Fluri DA, Witschi U, Passeraub A, Gutzwiller A, Fussenegger M. 2011. A designer network coordinating bovine artificial insemination by ovulation-triggered release of implanted sperms. J. Control. Release 150:23-29